These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24802410)

  • 21. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH.
    Sauter G; Gasser TC; Moch H; Richter J; Jiang F; Albrecht R; Novotny H; Wagner U; Bubendorf L; Mihatsch MJ
    Urol Res; 1997; 25 Suppl 1():S37-43. PubMed ID: 9079755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Demonstration of gene amplification in urinary bladder cancer by fluorescent in situ hybridization (FISH)].
    Sauter G; Moch H; Gudat F; Mihatsch MJ; Haley J; Meecker T; Waldman F
    Verh Dtsch Ges Pathol; 1993; 77():247-51. PubMed ID: 7511290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digitized microscopy in the diagnosis of bladder cancer: analysis of >3000 cases during a 7-month period.
    Marganski WA; El-Sirgany Costa V; Kilpatrick MW; Tafas T; Yim J; Matthews M
    Cancer Cytopathol; 2011 Aug; 119(4):279-89. PubMed ID: 21413160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A public-domain image processing tool for automated quantification of fluorescence in situ hybridisation signals.
    Konsti J; Lundin J; Jumppanen M; Lundin M; Viitanen A; Isola J
    J Clin Pathol; 2008 Mar; 61(3):278-82. PubMed ID: 17693574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copy number aberrations using multicolour fluorescence in situ hybridization (FISH) for prognostication in non-muscle-invasive bladder cancer (NIMBC).
    Matsuyama H; Ikemoto K; Eguchi S; Oga A; Kawauchi S; Yamamoto Y; Kawai Y; Matsumoto H; Hara T; Nagao K; Sakano S; Sasaki K
    BJU Int; 2014 Apr; 113(4):662-7. PubMed ID: 23890221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
    Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated signal pattern evaluation of a bladder cancer specific multiprobe-fish assay applying a user-trainable workstation.
    Pajor G; Alpar D; Kajtar B; Melegh B; Somogyi L; Kneif M; Bollmann D; Pajor L; Sule N
    Microsc Res Tech; 2012 Jun; 75(6):814-20. PubMed ID: 22615107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "FISHing" to detect urinary and other cancers: validation of an imaging system to aid in interpretation.
    Smith GD; Bentz JS
    Cancer Cytopathol; 2010 Feb; 118(1):56-64. PubMed ID: 20099312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
    Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
    Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters.
    Gallucci M; Guadagni F; Marzano R; Leonardo C; Merola R; Sentinelli S; Ruggeri EM; Cantiani R; Sperduti I; Lopez Fde L; Cianciulli AM
    J Clin Pathol; 2005 Apr; 58(4):367-71. PubMed ID: 15790699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-Study.
    Banek S; Schwentner C; Täger D; Pesch B; Nasterlack M; Leng G; Gawrych K; Bonberg N; Johnen G; Kluckert M; Gakis G; Todenhöfer T; Hennenlotter J; Brüning T; Stenzl A;
    Urol Oncol; 2013 Nov; 31(8):1656-62. PubMed ID: 22621963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology.
    Huang WT; Li LY; Pang J; Ruan XX; Sun QP; Yang WJ; Gao X
    Neoplasma; 2012; 59(4):355-60. PubMed ID: 22489689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of bladder cancer from the urine using fluorescence in situ hybridization technique.
    Riesz P; Lotz G; Páska C; Szendrôi A; Majoros A; Németh Z; Törzsök P; Szarvas T; Kovalszky I; Schaff Z; Romics I; Kiss A
    Pathol Oncol Res; 2007; 13(3):187-94. PubMed ID: 17922047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of fluorescence in situ hybridization of urine exfoliative cells in diagnosis of urinary bladder neoplasms].
    Chen N; Gong J; Zeng H; Wei Q; Zhu YC; Chen M; Zhou Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):109-13. PubMed ID: 21355314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical usefulness of fluorescence in situ hybridization for diagnosis and surveillance of bladder cancer.
    Song MJ; Lee HM; Kim SH
    Cancer Genet Cytogenet; 2010 Apr; 198(2):144-50. PubMed ID: 20362229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.
    Young TA; Burgess BL; Rao NP; Gorin MB; Straatsma BR
    Mol Vis; 2007 Dec; 13():2328-33. PubMed ID: 18199974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous detection of multiple genetic aberrations in single cells by spectral fluorescence in situ hybridization.
    Slovak ML; Tcheurekdjian L; Zhang FF; Murata-Collins JL
    Cancer Res; 2001 Feb; 61(3):831-6. PubMed ID: 11221864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer.
    Marano A; Pan Y; Li C; Pagliarulo A; Elmberger G; Tribukait B; Ekman P; Bergerheim U
    Eur Urol; 2000 Mar; 37(3):358-65. PubMed ID: 10720866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer.
    Mian C; Lodde M; Comploj E; Lusuardi L; Palermo S; Mian M; Maier K; Pycha A
    J Clin Pathol; 2006 Sep; 59(9):984-7. PubMed ID: 16935973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.